Dr. Zeitler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756Phone+1 603-650-4590Fax+1 603-650-0523
Summary
- Dr. Emily Zeitler is an electrophysiologist in Lebanon, NH and is affiliated with the Dartmouth-Hitchcock Medical Center. She received her medical degree from Emory University School of Medicine. She completed residency in internal medicine at Massachusetts General Hospital and fellowships in Cardiology, Clinical Research, and Electrophysiology at Duke University. She started practicing electrophysiology in 2018.
Education & Training
- Duke University HospitalFellowship, Cardiovascular Disease, 2012 - 2016
- Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
- Emory University School of MedicineClass of 2008
Certifications & Licensure
- NH State Medical License 2018 - 2026
- VT State Medical License Active through 2024
- NC State Medical License 2011 - 2018
- MA State Medical License 2010 - 2011
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Publications & Presentations
PubMed
- 9 citationsComparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs.Emily P Zeitler, T Jared Bunch, Rahul Khanna, Xiaozhou Fan, Maximiliano Iglesias
American Heart Journal. 2022-12-01 - 8 citationsStrategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association.Vinay Kini, Khadijah Breathett, Peter W Groeneveld, P Michael Ho, Brahmajee K Nallamothu
Circulation. Cardiovascular Quality and Outcomes. 2022-03-01 - 44 citationsStandardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T. Abraham, Mitchell A. Psotka, Mona Fiuzat, Gerasimos Filippatos, JoAnn Lindenfeld
JACC. Heart Failure. 2020-12-01
Abstracts/Posters
- [Board 169] Coverage With Evidence Development: Where Are We Now?Emily Zeitler, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/16/2019
Lectures
- Case #3 Medication Use in Long QT Syndrome2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Recalled ICD Generators in the NCDR-ICD Registry: Outcomes and Surveillance Implications2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Case 3 Debate: CHB After TAVR in Patient With EF < 35% - Minimal Device Therapy for Best Outcome2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Authored Content
- Reply the Benefit of Cardiac Resynchronization Therapy Is Not Hindered by the Number of ComorbiditiesOctober 2017
Press Mentions
- Study Finds Catheter Ablation Significantly Lowers Risk of Dementia in Patients with Atrial FibrillationNovember 10th, 2022
- Coverage with Evidence Development: Where Are We Now?August 1st, 2022
- Cardiac Resynchronization Therapy Boosts Care for Older HFrEF PatientsJanuary 17th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: